[1]McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association[J]. Circulation, 2017, 135(17):e927-e999. DOI: 10.1161/CIR.0000000000000484.
[2] Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006[J]. J Epidemiol, 2008, 18(4):167-172. DOI: 10.2188/jea.je2008001.
[3] JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)--digest version[J]. Circ J, 2010, 74(9):1989-2020. DOI: 10.1253/circj.cj-10-74-0903.
[4] 中华医学会儿科学分会心血管学组,中华儿科杂志编辑委员会.川崎病冠状动脉病变的临床处理建议(2020年修订版)[J].中华儿科杂志,2020,58(9):718-724. DOI:10.3760/cma.j.cn112140-20200422-00421.
[5] 刘芳.川崎病冠状动脉病变的心导管检查及冠状动脉造影[J].中华实用儿科临床杂志,2014,29(13):968-970. DOI:10.3760/cma.j.issn.2095-428X.2014.13.004.
[6] Dodge JT, Brown BG, Bolson EL, et al. Intrathoracic spatial location of specified coronary segments on the normal human heart. Applications in quantitative arteriography, assessment of regional risk and contraction, and anatomic display[J]. Circulation, 1988, 78(5 Pt 1):1167-1180. DOI: 10.1161/01.cir.78.5.1167.
[7] Onouchi Z, Shimazu S, Kiyosawa N, et al. Aneurysms of the coronary arteries in Kawasaki disease. An angiographic study of 30 cases[J]. Circulation, 1982, 66(1):6-13. DOI: 10.1161/01.cir.66.1.6.
[8] Fukazawa R, Kobayashi J, Ayusawa M, et al. JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease[J]. Circ J, 2020, 84(8):1348-1407. DOI: 10.1253/circj.CJ-19-1094.
[9] Ishii M, Ueno T, Akagi T, et al. Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease[J]. Pediatr Int, 2001, 43(5):558-562. DOI: 10.1046/j.1442-200x.2001.01464.x.
[10] Tsuda E, Tsujii N, Kimura K, et al. Distribution of Kawasaki disease coronary artery aneurysms and the relationship to coronary artery diameter[J]. Pediatr Cardiol, 2017, 38(5):932-940. DOI: 10.1007/s00246-017-1599-4.
[11] Suzuki A, Kamiya T, Kuwahara N, et al. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases[J]. Pediatr Cardiol, 1986, 7(1):3-9. DOI: 10.1007/BF02315475.
[12] 张锰,崔青,朱荻绮,等.川崎病合并冠状动脉病变患儿117例冠状动脉造影结果分析[J].中华实用儿科临床杂志,2023,38(7):491-496. DOI:10.3760/cma.j.cn101070- 20220913-01064.
[13] 王程浩,刘芳.川崎病所致冠状动脉病变的病理改变及结局[J].中华实用儿科临床杂志,2021,36(22):1757-1760. DOI:10.3760/cma.j.cn101070-20210510-00513.
[14] Ishii M, Ueno T, Akagi T, et al. Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease[J]. Pediatr Int, 2001, 43(5):558-562. DOI: 10.1046/j.1442-200x.2001.01464.x.
[15] Satou GM, Giamelli J, Gewitz MH. Kawasaki disease: diagnosis, management, and long-term implications[J]. Cardiol Rev, 2007, 15(4):163-169. DOI: 10.1097/CRD.0b013e31802ea93f.
[16] Takahashi K, Oharaseki T, Yokouchi Y. Histopathological aspects of cardiovascular lesions in Kawasaki disease[J]. Int J Rheum Dis, 2018, 21(1):31-35. DOI: 10.1111/1756-185X.13207.
[17] Orenstein JM, Shulman ST, Fox LM, et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study[J]. PLoS One, 2012, 7(6):e38998. DOI: 10.1371/journal.pone.0038998.
[18] Tsuda E, Kamiya T, Ono Y, et al. Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diameter during Kawasaki disease[J]. Pediatr Cardiol, 2005, 26(1):73-79. DOI: 10.1007/s00246-004- 0698-1.
[19] Tsuda E, Tsujii N, Hayama Y. Stenotic lesions and the maximum diameter of coronary artery aneurysms in Kawasaki disease[J]. J Pediatr, 2018, 194:165-170.e2. DOI: 10.1016/j.jpeds.2017.09.077.
[20]Kato T, Miura M, Kobayashi T, et al. Analysis of coronary arterial aneurysm regression in patients with Kawasaki disease by aneurysm severity: factors associated with regression[J]. J Am Heart Assoc, 2023, 12(3):e022417. DOI: 10.1161/JAHA.121.022417.
|